vs
COMMUNITY HEALTH SYSTEMS INC（CYH）与Roper Technologies（ROP）财务数据对比。点击上方公司名可切换其他公司
COMMUNITY HEALTH SYSTEMS INC的季度营收约是Roper Technologies的1.5倍（$3.1B vs $2.1B），Roper Technologies净利率更高（15.8% vs 3.5%，领先12.3%），Roper Technologies同比增速更快（11.3% vs -4.8%），Roper Technologies自由现金流更多（$507.0M vs $172.0M），过去两年Roper Technologies的营收复合增速更高（10.5% vs -0.5%）
社区卫生系统公司总部位于美国田纳西州富兰克林，是财富500强企业。按急症护理机构数量计算，该公司曾是美国最大的综合医院医疗服务提供商。2014年它旗下有约200家医院，到2021年机构数量缩减至约85家。
罗珀技术公司是一家专注于科技领域的控股企业，通过持有并运营多家不同细分赛道的科技公司，在科技产业投资与资产管理领域形成了成熟的业务体系，在全球相关市场具备较高的行业影响力。
CYH vs ROP — 直观对比
营收规模更大
CYH
是对方的1.5倍
$2.1B
营收增速更快
ROP
高出16.1%
-4.8%
净利率更高
ROP
高出12.3%
3.5%
自由现金流更多
ROP
多$335.0M
$172.0M
两年增速更快
ROP
近两年复合增速
-0.5%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $3.1B | $2.1B |
| 净利润 | $110.0M | $331.0M |
| 毛利率 | 85.6% | 69.4% |
| 营业利润率 | 14.5% | 27.2% |
| 净利率 | 3.5% | 15.8% |
| 营收同比 | -4.8% | 11.3% |
| 净利润同比 | 254.9% | 53.7% |
| 每股收益（稀释后） | $0.82 | $4.87 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CYHROP
| Q1 26 | — | $2.1B | ||
| Q4 25 | $3.1B | $2.1B | ||
| Q3 25 | $3.1B | $2.0B | ||
| Q2 25 | $3.1B | $1.9B | ||
| Q1 25 | $3.2B | $1.9B | ||
| Q4 24 | $3.3B | $1.9B | ||
| Q3 24 | $3.1B | $1.8B | ||
| Q2 24 | $3.1B | $1.7B |
净利润CYHROP
| Q1 26 | — | $331.0M | ||
| Q4 25 | $110.0M | $428.4M | ||
| Q3 25 | $130.0M | $398.5M | ||
| Q2 25 | $282.0M | $378.3M | ||
| Q1 25 | $-13.0M | $331.1M | ||
| Q4 24 | $-71.0M | $462.3M | ||
| Q3 24 | $-391.0M | $367.9M | ||
| Q2 24 | $-13.0M | $337.1M |
毛利率CYHROP
| Q1 26 | — | 69.4% | ||
| Q4 25 | 85.6% | 69.5% | ||
| Q3 25 | 85.1% | 69.5% | ||
| Q2 25 | 85.0% | 69.2% | ||
| Q1 25 | 84.5% | 68.7% | ||
| Q4 24 | 84.5% | 68.3% | ||
| Q3 24 | 84.8% | 69.2% | ||
| Q2 24 | 84.6% | 69.5% |
营业利润率CYHROP
| Q1 26 | — | 27.2% | ||
| Q4 25 | 14.5% | 28.6% | ||
| Q3 25 | 7.9% | 28.4% | ||
| Q2 25 | 16.3% | 28.2% | ||
| Q1 25 | 9.0% | 27.9% | ||
| Q4 24 | 8.5% | 28.0% | ||
| Q3 24 | -6.6% | 28.1% | ||
| Q2 24 | 7.6% | 28.8% |
净利率CYHROP
| Q1 26 | — | 15.8% | ||
| Q4 25 | 3.5% | 20.8% | ||
| Q3 25 | 4.2% | 19.8% | ||
| Q2 25 | 9.0% | 19.5% | ||
| Q1 25 | -0.4% | 17.6% | ||
| Q4 24 | -2.2% | 24.6% | ||
| Q3 24 | -12.7% | 20.8% | ||
| Q2 24 | -0.4% | 19.6% |
每股收益（稀释后）CYHROP
| Q1 26 | — | $4.87 | ||
| Q4 25 | $0.82 | $3.97 | ||
| Q3 25 | $0.96 | $3.68 | ||
| Q2 25 | $2.09 | $3.49 | ||
| Q1 25 | $-0.10 | $3.06 | ||
| Q4 24 | $-0.53 | $4.29 | ||
| Q3 24 | $-2.95 | $3.40 | ||
| Q2 24 | $-0.10 | $3.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $260.0M | $382.9M |
| 总债务越低越好 | $10.4B | $9.7B |
| 股东权益账面价值 | $-1.4B | $18.8B |
| 总资产 | $13.2B | $34.6B |
| 负债/权益比越低杠杆越低 | — | 0.52× |
8季度趋势，按日历期对齐
现金及短期投资CYHROP
| Q1 26 | — | $382.9M | ||
| Q4 25 | $260.0M | $297.4M | ||
| Q3 25 | $123.0M | $320.0M | ||
| Q2 25 | $456.0M | $242.4M | ||
| Q1 25 | $431.0M | $372.8M | ||
| Q4 24 | $37.0M | $188.2M | ||
| Q3 24 | $33.0M | $269.6M | ||
| Q2 24 | $39.0M | $251.5M |
总债务CYHROP
| Q1 26 | — | $9.7B | ||
| Q4 25 | $10.4B | $9.3B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $11.5B | $7.6B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益CYHROP
| Q1 26 | — | $18.8B | ||
| Q4 25 | $-1.4B | $19.9B | ||
| Q3 25 | $-1.5B | $20.0B | ||
| Q2 25 | $-1.6B | $19.6B | ||
| Q1 25 | $-1.9B | $19.2B | ||
| Q4 24 | $-1.9B | $18.9B | ||
| Q3 24 | $-1.8B | $18.5B | ||
| Q2 24 | $-1.4B | $18.1B |
总资产CYHROP
| Q1 26 | — | $34.6B | ||
| Q4 25 | $13.2B | $34.6B | ||
| Q3 25 | $13.2B | $34.6B | ||
| Q2 25 | $13.6B | $33.2B | ||
| Q1 25 | $13.9B | $31.4B | ||
| Q4 24 | $14.1B | $31.3B | ||
| Q3 24 | $13.9B | $31.6B | ||
| Q2 24 | $14.4B | $29.8B |
负债/权益比CYHROP
| Q1 26 | — | 0.52× | ||
| Q4 25 | — | 0.47× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.40× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $266.0M | — |
| 自由现金流经营现金流 - 资本支出 | $172.0M | $507.0M |
| 自由现金流率自由现金流/营收 | 5.5% | 24.2% |
| 资本支出强度资本支出/营收 | 3.0% | 0.5% |
| 现金转化率经营现金流/净利润 | 2.42× | — |
| 过去12个月自由现金流最近4个季度 | $208.0M | — |
8季度趋势，按日历期对齐
经营现金流CYHROP
| Q1 26 | — | — | ||
| Q4 25 | $266.0M | $738.0M | ||
| Q3 25 | $69.0M | $869.5M | ||
| Q2 25 | $88.0M | $404.1M | ||
| Q1 25 | $120.0M | $528.7M | ||
| Q4 24 | $216.0M | $722.2M | ||
| Q3 24 | $67.0M | $755.4M | ||
| Q2 24 | $101.0M | $384.1M |
自由现金流CYHROP
| Q1 26 | — | $507.0M | ||
| Q4 25 | $172.0M | — | ||
| Q3 25 | $4.0M | — | ||
| Q2 25 | $-3.0M | — | ||
| Q1 25 | $35.0M | — | ||
| Q4 24 | $107.0M | — | ||
| Q3 24 | $-3.0M | — | ||
| Q2 24 | $13.0M | — |
自由现金流率CYHROP
| Q1 26 | — | 24.2% | ||
| Q4 25 | 5.5% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | -0.1% | — | ||
| Q1 25 | 1.1% | — | ||
| Q4 24 | 3.3% | — | ||
| Q3 24 | -0.1% | — | ||
| Q2 24 | 0.4% | — |
资本支出强度CYHROP
| Q1 26 | — | 0.5% | ||
| Q4 25 | 3.0% | — | ||
| Q3 25 | 2.1% | — | ||
| Q2 25 | 2.9% | — | ||
| Q1 25 | 2.7% | — | ||
| Q4 24 | 3.3% | — | ||
| Q3 24 | 2.3% | — | ||
| Q2 24 | 2.8% | — |
现金转化率CYHROP
| Q1 26 | — | — | ||
| Q4 25 | 2.42× | 1.72× | ||
| Q3 25 | 0.53× | 2.18× | ||
| Q2 25 | 0.31× | 1.07× | ||
| Q1 25 | — | 1.60× | ||
| Q4 24 | — | 1.56× | ||
| Q3 24 | — | 2.05× | ||
| Q2 24 | — | 1.14× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CYH
| Managed Care And Other Third Party Payors | $1.5B | 49% |
| Medicare Managed Care | $570.0M | 18% |
| Medicare | $512.0M | 16% |
| Medicaid | $464.0M | 15% |
| Self Pay Revenue | $34.0M | 1% |
ROP
暂无分部数据
